The response of adult female mice to diazepam (DZ) can be sculpted by the prenatal experience with the drug. Experiments were performed in ICR strain (Harlan México) mice exposed in utero to DZ. They were born from dams injected (s.c.) with 2.7 mg/kg/bw of DZ or just saline solution from day 6 to 17 of pregnancy. They were maintained at 12:12 dark/light cycles with food and water ad libitum. On the experimental day, mice were introduced in an activity meter (actometer) for 5 min. Recordings were run at 25 mm/min. The time they remained motionless or clearly sleepy was determined in millimeters. After that, all animals received (s.c.) 2.7 mg/kg/bw of DZ; 15 min later they were introduced into the actometer again for 5 min. Before DZ, control animals injected with saline during gestation showed 1.57 +/- 0.53 mm and the experimental (DZ) prenatally exposed to DZ, 3.69 +/- 1.72 mm (p =0.27). After DZ, control animals remained motionless for 37.27 +/- 6.77 mm and DZ mice, 59.95 +/- 7.10 mm (p=0.03). This result indicates a significantly larger response to DZ in the pretreated animals, suggesting that exposure of the developing fetus to the drug may lead to persistent (14 months) morphological alterations in several areas of the central nervous system with physiological repercussion on motor behavior and learning, sometimes attributed to brain circuitry modifications or to the developmental vulnerability of synaptic neurochemical mechanisms.
Download full-text PDF |
Source |
---|
J Clin Invest
January 2025
Laboratory of Translational Oncology and Translational Cancer Therapeutics, Warren Alpert Medical School of Brown University, Providence, United States of America.
Radiotherapy can be limited by pneumonitis which is impacted by innate immunity, including pathways regulated by TRAIL death receptor DR5. We investigated whether DR5 agonists could rescue mice from toxic effects of radiation and found two different agonists, parenteral PEGylated trimeric-TRAIL (TLY012) and oral TRAIL-Inducing Compound (TIC10/ONC201) could reduce pneumonitis, alveolar-wall thickness, and oxygen desaturation. Lung protection extended to late effects of radiation including less fibrosis at 22-weeks in TLY012-rescued survivors versus un-rescued surviving irradiated-mice.
View Article and Find Full Text PDFDiabetes
January 2025
Department of Biology & Institute of Biochemistry, Carleton University, Ottawa, ON, Canada.
Cancer survivors have an increased risk of developing Type 2 diabetes compared to the general population. Patients treated with cisplatin, a common chemotherapeutic agent, are more likely to develop metabolic syndrome and Type 2 diabetes than age- and sex-matched controls. Surprisingly, the impact of cisplatin on pancreatic islets has not been reported.
View Article and Find Full Text PDFImmunol Res
January 2025
Department of Otolaryngology, Qingdao Traditional Chinese Medicine Hospital (Qingdao Hiser Hospital), Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao, 266033, Shandong, People's Republic of China.
Baicalein, one of the major active flavonoids found in Scutellaria baicalensis, has been revealed to exhibit potent anti-inflammatory properties in allergic airway inflammation. This study aimed to explore the role of baicalein and its relevant mechanism in the treatment of allergic rhinitis (AR). The bioinformatics tools were used to predict the targets of baicalein and AR-related genes.
View Article and Find Full Text PDFMetab Brain Dis
January 2025
Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Neuroinflammation and mitochondrial dysfunction are early events in Alzheimer's disease (AD) and contribute to neurodegeneration and cognitive impairment. Evidence suggests that the inflammatory axis mediated by macrophage migration inhibitory factor (MIF) binding to its receptor, CD74, plays an important role in many central nervous system (CNS) disorders such as AD. Our group has developed DRhQ, a novel CD74 binding construct which competitively inhibits MIF binding, blocks macrophage activation and migration into the CNS, enhances anti-inflammatory microglia cell numbers and reduces pro-inflammatory gene expression.
View Article and Find Full Text PDFImmunol Res
January 2025
Inflammatory Bowel Disease Clinic, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga #15, Col. Belisario Domínguez Sección XVI, 14080, Mexico City, CPCDMX, Mexico.
The ABCC subfamily contains thirteen members. Nine of these transporters are called multidrug resistance proteins (MRPs). The MRPs have been associated with developing ulcerative colitis (UC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!